Also known as آسٹیوپوروسس مینجمنٹ
Internal Medicine Specialist
M.B.B.S, F.C.P.S (Medicine), F.C.P.S (Endocrinology Diabetes and Metabolism)
Internal Medicine Specialist
M.B.B.S, F.C.P.S (Medicine), F.C.P.S (Endocrinology Diabetes and Metabolism)
Endocrinologist
MBBS, Diploma in Diabetology, MSc (Diabetes & Endocrinology)
Endocrinologist
MBBS, Diploma in Diabetology, MSc (Diabetes & Endocrinology)
Diabetologist
M.B.B.S, MRCP (UK), MRCP (London), Specialty Certificate in Endocrinology and Diabetes
Diabetologist
M.B.B.S, MRCP (UK), MRCP (London), Specialty Certificate in Endocrinology and Diabetes
Family Physician
M.B.B.S, D.D.M
Gastroenterologist
M.B.B.S., F.C.P.S. (Gastroenterology)
Cardiologist
MBBS, FCPS (Medicine), FCPS (Cardiology)
Internal Medicine Specialist
MBBS, FCPS (Medicine)
Internal Medicine Specialist
MBBS, FCPS (Medicine)
Gastroenterologist
MBBS, FRCP, FEBGH, MRCP, CCST
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures